Found: 7
Select item for more details and to access through your institution.
Atorvastatin does not ameliorate nephrogenic diabetes insipidus induced by lithium or potassium depletion in mice.
- Published in:
- Physiological Reports, 2021, v. 9, n. 21, p. 1, doi. 10.14814/phy2.15111
- By:
- Publication type:
- Article
Early targets of lithium in rat kidney inner medullary collecting duct include p38 and ERK1/2.
- Published in:
- Kidney International, 2014, v. 86, n. 4, p. 757, doi. 10.1038/ki.2014.107
- By:
- Publication type:
- Article
Potassium depletion induces cellular conversion in the outer medullary collecting duct altering Notch signaling pathway.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-61882-7
- By:
- Publication type:
- Article
Proteomic analysis of urinary exosomes from patients with lithium‐induced nephrogenic diabetes insipidus.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.0R585
- By:
- Publication type:
- Article
Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.
- Published in:
- BMC Psychiatry, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12888-018-1793-9
- By:
- Publication type:
- Article
Absence of E-Cadherin and β-Catenin in the Basal Plasma Membrane of Collecting Duct Cells During NDI Development and Recovery.
- Published in:
- Journal of Histochemistry & Cytochemistry, 2023, v. 71, n. 7, p. 357, doi. 10.1369/00221554231185809
- By:
- Publication type:
- Article
A double‐blind, randomized, placebo‐controlled pilot trial of atorvastatin for nephrogenic diabetes insipidus in lithium users.
- Published in:
- Bipolar Disorders, 2021, v. 23, n. 1, p. 66, doi. 10.1111/bdi.12973
- By:
- Publication type:
- Article